By Jeff Montgomery ( March 11, 2016, 10:57 PM EST) -- A North Carolina-based hedge fund has emerged as a stalking horse investor in Chapter 11 turnaround efforts by KaloBios Pharmaceuticals Inc., with a $10 million deal that would sharply limit the role of controversial former lead investor Martin Shkreli....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.